[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:diffuse-intrinsic-pontine-glioma:histone-h3-lysine-28":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Diffuse Intrinsic Pontine Glioma","Histone H3 Lysine 28",3,[8,16,23],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06838676","ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas",[12],"Phase 2","RECRUITING","2026-08-26T02:15:02.712396Z","2026-06-16T05:54:07.925383Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06305910","CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG\u002FDIPG in Children and Young Adults",[20],"Phase 1","2026-08-26T02:16:01.079019Z","2026-05-05T02:43:29.586016Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":28,"content_modified":29},"NCT06639607","PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma\u002FHigh-grade Glioma and Recurrent Diffuse Midline Glioma\u002FHigh-grade Glioma, Medulloblastoma, and Ependymoma",[27],"Phase 1\u002FPhase 2","2026-08-03T00:58:26.564367Z","2026-07-05T05:32:16.689130Z"]